122 related articles for article (PubMed ID: 28067024)
1. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function.
Engstler AJ; Sellmann C; Jin CJ; Brandt A; Herz K; Priebs J; Bergheim I
Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 28067024
[TBL] [Abstract][Full Text] [Related]
2. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
[TBL] [Abstract][Full Text] [Related]
3. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis.
Sellmann C; Jin CJ; Degen C; De Bandt JP; Bergheim I
J Nutr; 2015 Oct; 145(10):2280-6. PubMed ID: 26246326
[TBL] [Abstract][Full Text] [Related]
4. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
6. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
[No Abstract] [Full Text] [Related]
7. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function.
Wang YC; Jin QM; Kong WZ; Chen J
Int J Clin Exp Pathol; 2015; 8(5):5203-9. PubMed ID: 26191218
[TBL] [Abstract][Full Text] [Related]
9. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I
Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046
[TBL] [Abstract][Full Text] [Related]
10. The combination of Ilexhainanoside D and ilexsaponin A
Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis.
Wang Y; Liang K; Kong W
Arch Med Res; 2019 Jan; 50(1):2-9. PubMed ID: 31101239
[TBL] [Abstract][Full Text] [Related]
12. Effects of compound Ginkgo biloba on intestinal permeability in rats with alcohol-induced liver injury.
Li H; Qiu P; Wang J; Niu C; Pan S
Food Funct; 2015 Feb; 6(2):470-8. PubMed ID: 25473797
[TBL] [Abstract][Full Text] [Related]
13. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic Effects of 1,25(OH)
Ma L; Ishigami M; Honda T; Yokoyama S; Yamamoto K; Ishizu Y; Kuzuya T; Hayashi K; Hirooka Y; Goto H
Dig Dis Sci; 2019 Sep; 64(9):2581-2590. PubMed ID: 30825110
[TBL] [Abstract][Full Text] [Related]
15. Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
Matsumoto K; Ichimura M; Tsuneyama K; Moritoki Y; Tsunashima H; Omagari K; Hara M; Yasuda I; Miyakawa H; Kikuchi K
PLoS One; 2017; 12(6):e0175406. PubMed ID: 28632732
[TBL] [Abstract][Full Text] [Related]
16. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression.
Peng JH; Cui T; Huang F; Chen L; Zhao Y; Xu L; Xu LL; Feng Q; Hu YY
J Pharmacol Exp Ther; 2013 Mar; 344(3):646-54. PubMed ID: 23277536
[TBL] [Abstract][Full Text] [Related]
17. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
19. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Spruss A; Kanuri G; Stahl C; Bischoff SC; Bergheim I
Lab Invest; 2012 Jul; 92(7):1020-32. PubMed ID: 22525431
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
